Reduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination

被引:78
作者
Papadopoulou, B
Roy, G
Breton, M
Kündig, C
Dumas, C
Fillion, I
Singh, AK
Olivier, M
Ouellette, M
机构
[1] CHUL, Ctr Rech, Ctr Rech Infectiol, Quebec City, PQ, Canada
[2] Univ Laval, Fac Med, Div Microbiol, Quebec City, PQ G1K 7P4, Canada
关键词
D O I
10.1128/IAI.70.1.62-68.2002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pterins are essential for the growth of Leishmania species, and recent work has led to the isolation of the biopterin transporter BT1. In this study, we inactivated the Leishmania donovani biopterin transporter BT1 by gene disruption mediated by homologous recombination. No transport of biopterin was detected in this mutant. The L. donovani BT1 null mutant showed a much lesser capacity for inducing infection in mice than wild-type parasites and could elicit protective immunity in mice susceptible to infection against a L. donovani challenge. Splenocytes isolated from mice immunized with the BT1 null mutant parasites produced significant amounts of interferon gamma following stimulation with L. donovani promastigotes as measured by enzyme-linked immunosorbent assay and enzyme-linked immunospot assays. Overall, these results show that by genetically manipulating the pterin transport in L. donovani, it is possible to generate an attenuated organism that could be part of a vaccination strategy.
引用
收藏
页码:62 / 68
页数:7
相关论文
共 48 条
  • [1] Subunit vaccination of mice against new world cutaneous leishmaniasis: Comparison of three proteins expressed in amastigotes and six adjuvants
    Aebischer, T
    Wolfram, M
    Patzer, SI
    Ilg, T
    Wiese, M
    Overath, P
    [J]. INFECTION AND IMMUNITY, 2000, 68 (03) : 1328 - 1336
  • [2] Alexander J, 1998, J IMMUNOL, V161, P6794
  • [3] Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
    Berman, JD
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (04) : 684 - 703
  • [4] The role of nitric oxide in innate immunity
    Bogdan, CT
    Röllinghoff, M
    Diefenbach, A
    [J]. IMMUNOLOGICAL REVIEWS, 2000, 173 : 17 - 26
  • [5] BRUN R, 1979, ACTA TROP, V36, P289
  • [6] IMMUNOLOGICAL MARKERS OF CLINICAL EVOLUTION IN CHILDREN RECENTLY INFECTED WITH LEISHMANIA-DONOVANI-CHAGASI
    CARVALHO, EM
    BARRAL, A
    PEDRALSAMPAIO, D
    BARRALNETTO, M
    BADARO, R
    ROCHA, H
    JOHNSON, WD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) : 535 - 540
  • [7] PLASTICITY IN CHROMOSOME-NUMBER AND TESTING OF ESSENTIAL GENES IN LEISHMANIA BY TARGETING
    CRUZ, AK
    TITUS, R
    BEVERLEY, SM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (04) : 1599 - 1603
  • [8] Regulation of differentiation to the infective stage of the protozoan parasite Leishmania major by tetrahydrobiopterin
    Cunningham, ML
    Titus, RG
    Turco, SJ
    Beverley, SM
    [J]. SCIENCE, 2001, 292 (5515) : 285 - 287
  • [9] Immunization with recombinant LD1 antigens protects against experimental leishmaniasis
    Dole, VS
    Raj, VS
    Ghosh, A
    Madhubala, R
    Myler, PJ
    Stuart, KD
    [J]. VACCINE, 2000, 19 (4-5) : 423 - 430
  • [10] Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages
    Dumas, C
    Ouellette, M
    Tovar, J
    Cunningham, ML
    Fairlamb, AH
    Tamar, S
    Olivier, M
    Papadopoulou, B
    [J]. EMBO JOURNAL, 1997, 16 (10) : 2590 - 2598